NCT06552182

Phase 1 Study in Diabetes Mellitus(Fasting)

An Open-label, Randomized, Fasting, Single-dose, 2-sequence, 2-period, Crossover Phase 1 Study After Administration of HUC2-344 and Co-administration of HUC2-344-R1 and HUC2-344-R2 in Healthy Volunteers

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 40 (actual)
• Sponsor: Huons Co., Ltd. · Industry
• Sex: All
• Age: 19 Years
• Healthy volunteers: Accepted

Summary

An open-label, randomized, fasting, single-dose, 2-sequence, 2-period, crossover phase 1 study in healthy volunteers.

Detailed description

An Open-label, Randomized, Fasting, Single-dose, 2-sequence, 2-period, Crossover Phase 1 Study to Evaluate the Pharmacokinetics and the Safety After Administration of HUC2-344 and Co-administration of HUC2-344-R1 and HUC2-344-R2 in Healthy Volunteers.

Conditions

• Diabetes
• Diabetes Mellitus

Interventions

Type	Name	Description
DRUG	HUC2-344	per oral
DRUG	HUC2-344-R1, HUC2-344-R2	per oral

Timeline

• Start date: 2024-01-17
• Primary completion: 2024-02-15
• Completion: 2024-03-18
• First posted: 2024-08-13
• Last updated: 2024-08-13

Locations

1 site across 1 country: South Korea